CARLSON INV. ZY 13 Cash Flow Conversion Efficiency
CARLSON INV. ZY 13 cash flow conversion efficiency. Based on the latest financial reports, CARLSON INV. ZY 13 (2HB) has a cash flow conversion efficiency ratio of -0.001x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-18.38K ≈ $-21.49K USD) by net assets (€27.21 Million ≈ $31.81 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of CARLSON INV. ZY 13 (2021–2025)
Cash flow conversion efficiency of CARLSON INV. ZY 13 from 2021 to 2025. This chart illustrates how CARLSON INV. ZY 13's cash flow conversion efficiency has evolved over time, based on yearly financial data. View CARLSON INV. ZY 13 (2HB) share price today for real-time trading data and today's change.
CARLSON INV. ZY 13 Cash Flow Conversion Ratio Explained
CARLSON INV. ZY 13 cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
CARLSON INV. ZY 13 Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of CARLSON INV. ZY 13 ranked by their cash flow conversion efficiency. Also see CARLSON INV. ZY 13 stock valuation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Strategem Capital Corp
V:SGE
|
0.008x |
|
Traws Pharma Inc
NASDAQ:TRAW
|
-4.438x |
|
Ignite Ltd
AU:IGN
|
0.302x |
|
ARK Resources Bhd
KLSE:7007
|
-0.760x |
|
UNITH LTD.
F:CM30
|
N/A |
|
Carmell Therapeutics Corporation
NASDAQ:CTCX
|
0.198x |
|
Kane Biotech Inc
V:KNE
|
0.912x |
|
Resources & Energy Group Ltd
AU:REZ
|
-0.115x |
Annual Cash Flow Conversion Efficiency for CARLSON INV. ZY 13 (2021–2025)
The table below shows the annual cash flow conversion efficiency of CARLSON INV. ZY 13 from 2021 to 2025. Review cash generation quality of CARLSON INV. ZY 13 to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €27.21 Million ≈ $31.81 Million |
€-10.62 Million ≈ $-12.42 Million |
-0.390x | -814.47% |
| 2024-12-31 | €15.93 Million ≈ $18.62 Million |
€-679.81K ≈ $-794.77K |
-0.043x | +64.25% |
| 2023-12-31 | €24.03 Million ≈ $28.09 Million |
€-2.87 Million ≈ $-3.35 Million |
-0.119x | -254.67% |
| 2022-12-31 | €25.54 Million ≈ $29.86 Million |
€1.97 Million ≈ $2.30 Million |
0.077x | +244.51% |
| 2021-12-31 | €33.04 Million ≈ $38.63 Million |
€-1.76 Million ≈ $-2.06 Million |
-0.053x | -- |
About CARLSON INV. ZY 13
Carlson Investments SE is a venture capital firm specializing in seed, early, growth capital and pre-IPO investments. The firm prefer to make investments in financial, medical, and deep technology industries. The firm seeks to make investments in Europe, North America and Asia, with a particular focus on Central and Eastern Europe. The company was formerly known as Hotblok S.A. and changed its na… Read more